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Anesthetic Techniques Influence the
Induction of Pulmonary Capillary 
Hemorrhage During Diagnostic 
Ultrasound Scanning in Rats
ulsed ultrasound (US) can induce pulmonary capillary
hemorrhage in mammals, which raises some concern for
diagnostic US in medicine. This bioeffect was discovered
more than 20 years ago1 and was evaluated in subsequent research
for dependence on various pulsed US parameters to assess the pos-
sible risk for diagnostic US. Reported exposure thresholds for pul-
monary capillary hemorrhage found in studies of the response to
varied peak rarefactional pressure amplitude were reviewed by the
American Institute of Ultrasound in Medicine.2 The results were
interpreted in terms of the mechanical index (MI), which is an expo-
sure index displayed on the screens of most US machines. The MI
concept can be used for research by adjusting the peak rarefactional
pressure amplitude measured in water for attenuation and dividing
by the square root of the pulse center frequency. The thresholds,
which were obtained mostly in anesthetized mice, corresponded
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Objectives—Pulmonary capillary hemorrhage can be induced by diagnostic ultrasound
(US) during direct pulmonary US scanning in rats. The influence of specific anesthetic
techniques on this bioeffect was examined.
Methods—Ketamine plus xylazine has been used previously. In this study, the influence
of intraperitoneal injections of ketamine and pentobarbital, inhalational isoflurane, and
the supplemental use of xylazine with ketamine and isoflurane was tested. A diagnostic
US machine with a 7.6-MHz linear array was used to image the right lung of anesthetized
rats in a warmed water bath at different mechanical index (MI) settings. Pulmonary
capillary hemorrhage was assessed by measuring comet tail artifacts in the image and by
morphometry of the hemorrhagic areas on excised lungs.
Results—Pulmonary capillary hemorrhage was greatest for pentobarbital, lower for
inhalational isoflurane, and lowest for ketamine anesthesia, with occurrence thresholds
at MIs of about 0.44, 0.8, and 0.8, respectively. Addition of xylazine produced a sub-
stantial increase in hemorrhage and a significant proportion of hemorrhage occurrence
for ketamine at an MI of 0.7 (P < .01) and for isoflurane at an MI of 0.52 (P < .01).
Conclusions—Ketamine plus xylazine and pentobarbital yield lower thresholds than
ketamine or isoflurane alone by nearly a factor of 2 in MI. These results suggest that the
choice of the anesthetic agent substantially modifies the relative risks of pulmonary cap-
illary hemorrhage from pulmonary US. 
Key Words—anesthetic techniques; comet tail artifact; point-of-care ultrasound;
pulmonary hemorrhage; pulmonary ultrasound; ultrasound bioeffects 
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roughly to an MI value of 0.63.2 For reference, the guide-
line upper limit for diagnostic US is an MI of 1.9.3
Ultrasound-induced pulmonary capillary hemorrhage was
found at about the same derated peak rarefactional pres-
sure amplitudes in mice, rats, rabbits, pigs, and monkeys.
A meta-analysis of 14 studies in mice and rats found that
the pulmonary capillary hemorrhage effect had widely vary-
ing thresholds and appeared to depend on physical param-
eters, including pulse duration, pulse repetition frequency,
and exposure duration, in addition to peak rarefactional pres-
sure amplitude and frequency.4 In another authoritative
review by the American Institute of Ultrasound in Medicine,
patient pulmonary US exposure was expected to occur
during incidental exposure to echocardiography, which
was not thought to pose a consistently defined risk.5 How-
ever, this overview of the pulmonary capillary hemorrhage
problem has changed in recent years for two reasons.
First, most of the available data were obtained with
pulsed US from laboratory exposure systems, and the appli-
cability to actual diagnostic US was uncertain. Diagnostic
US was used for studies in monkeys6 and rats,7 but the results
were mixed. A study of human lungs after echocardiography
indicated that 3.5-MHz diagnostic US up to 2.4 MPa
(MI = 1.3), which was thought to interact with the lung as
incidental exposure, did not cause pulmonary capillary
hemorrhage.8 In a recent study in rats from our laboratory,
diagnostic US from a 7.6-MHz linear array was used to
directly scan the right lung of anesthetized rats in a warmed
water bath.9 The image displayed growing comet tail
artifacts, which were indicative of pulmonary capillary
hemorrhage on the surface of the lung. Pulmonary capil-
lary hemorrhage was observed for several groups of rats
scanned at a range of MI settings for 5 minutes, and a thresh-
old for hemorrhage occurrence was indicated for an MI of
about 0.44. This result appears to be lower than expected
from the meta-analysis of physical parameters.4 The etiol-
ogy of pulmonary capillary hemorrhage induced by diag-
nostic US remains poorly understood.
Second, direct pulmonary US examination has
become a valuable diagnostic aid for pneumonia, pulmonary
edema and effusion, pulmonary embolism, atelectasis, dif-
fuse parenchymal disease, adult and newborn respiratory
distress syndrome, and lung cancer.10 Diagnostic US imag-
ing has largely replaced chest radiography for pleural effu-
sion, pneumothorax, hemothorax, and posttraumatic lung
contusion.11,12 Pulmonary US is rapidly becoming routine
in intensive care,13–15 emergency care,16 and other point-of-
care settings.17 This adoption of routine pulmonary US
completely changes the diagnostic US-induced pulmonary
capillary hemorrhage problem of incidental exposure to
one of direct, deliberate examination. The problem requires
further examination from new perspectives to clarify poten-
tial patient risks and provide guidance for the safe use of
pulmonary US.
One aspect of the problem in need of elaboration is
the role of biological and physiologic factors. Age is one
biological factor that has been explored. For mice and rats,
pulmonary capillary hemorrhage thresholds appeared to
have little dependence on age.18,19 Neonatal swine also had
pulmonary capillary hemorrhage thresholds comparable to
those of adult mice.20 For older pigs, the experimentation is
more difficult due to the size of the animals, but this animal
model more closely simulates humans. O’Brien et al21 found
that older pigs were more sensitive than neonatal or middle-
aged pigs to 3.1-MHz pulsed US for 10-second exposures.
Other physiologic conditions may also be important.
One key factor for research is the use of anesthetics. For gen-
eral anesthesia in mice and rats, intraperitoneal injection of
ketamine plus xylazine is typically used; for example, studies
of rats and mice reviewed by Church and O’Brien4 all used
ketamine plus xylazine. The doses were 87 mg/kg ketamine
plus 13 mg/kg xylazine in rats or mice,21–24 100 mg/kg
ketamine plus 10 mg/kg xylazine in rats,7 and 200
mg/kg ketamine plus 10 mg/kg xylazine in mice.1,17,25,26
The presently recommended anesthetic doses of 91 mg/kg
ketamine and 9 mg/kg xylazine were used in our previous
study.9
Ketamine is a dissociative anesthetic, which immobi-
lizes with little respiratory depression, whereas xylazine is
a sedative and analgesic, which produces substantial car-
diovascular and respiratory depression.27 Xylazine has
been reported to induce pulmonary edema in rats at rela-
tively high doses of 21 to 45 mg/kg.28,29 In a previous study
using bronchoalveolar lavage albumin levels as represen-
tative of permeability injury, the normal doses of xylazine
used for anesthesia did not produce a significant injury
when compared with ketamine alone. However, the omis-
sion of xylazine reduced the size of the comet tail artifacts
produced during US scanning and significantly reduced
the erythrocyte count in the bronchoalveolar lavage fluid
found after scanning.30 Statistical analysis using analysis of
variance (ANOVA) suggested that a synergistic interaction
occurred between the US scanning and the use of xylazine.
The goal of this study was to examine the influence of
commonly used anesthetics and drug combinations on the
induction of pulmonary capillary hemorrhage by diagnostic
US scanning, using our previous methods.9 A common
anesthetic for rodents is pentobarbital. This barbiturate
yields prolonged anesthesia and can cause cardiovascular
and respiratory system depression.27 Inhalation anesthesia
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is typically used for larger animals but is also valuable for
short-term anesthesia in rodents. Isoflurane typically is
applied at 1% to 5% in oxygen or air from a vaporizing
machine. Thresholds were determined using ketamine
without xylazine, pentobarbital, and isoflurane. Pulmonary
capillary hemorrhage results for ketamine with and without
xylazine were compared. In addition, the effect of the addi-
tion of xylazine to isoflurane was tested. The results show
substantial influences of the specific anesthetics on US-
induced pulmonary capillary hemorrhage. 
Materials and Methods
Animal Preparation
All in vivo animal procedures were conducted with the
approval and guidance of the University Committee on
Use and Care of Animals. Female Sprague Dawley rats
(CD IGS strain; Charles River Laboratories, Wilmington,
MA) were used for this research. The study progressed in
3 parts involving ketamine, pentobarbital, or isoflurane
anesthesia.
For the ketamine anesthesia, 36 rats weighing 224 ±
15 g (mean ± SD) were used, with 2 animals dying shortly
after administration of the agent. There were 6 scan
groups of 5 rats each and a sham group of 4 rats. The keta-
mine (Ketaved ketamine hydrochloride injection; Vedco,
Inc, St Joseph, MO) was injected to deliver 100 mg/kg
intraperitoneally for 3 scan groups and the sham group. In
the additional 3 scan groups, ketamine 91 at mg/kg intraperi-
toneally was supplemented with 9 mg/kg intraperitoneal
xylazine (AnaSed xylazine injection; Akorn, Inc, Decatur,
IL), given either before the US scanning or immediately
after scanning, representing a control for the potential
effects of xylazine that are not dependent on scanning.
For pentobarbital anesthesia, 31 rats weighing 242 ± 14
g were used, with 1 animal excluded for technical problems.
There were 6 groups of 5 rats each, including 5 scan groups
and 1 sham group. Pentobarbital (Nembutal sodium
solution; Akorn, Inc) was injected at a dose of 50 mg/kg
intraperitoneally.
Inhalational use of isoflurane produces moderate
cardiovascular and respiratory depression but can be rap-
idly modulated to yield the required level of anesthesia.26
Oxygen was tried as the carrier gas in preliminary testing;
however, this method seemed to produce spontaneous
comet tail artifacts and areas of atelectasis on some rat’s
lungs. The use of 100% oxygen can lead to problems with
pulmonary function due to absorptive atelectasis, a seri-
ous potential problem with inhalational anesthesia.31
This problem can be mitigated by use of lower oxygen con-
centrations or air (ie, 20% oxygen). For this study, air was
the isoflurane vehicle. Thirty rats weighing 227 ± 10 g were
assigned to 6 scan groups with air as the carrier gas, miti-
gating the problems found with oxygen. The isoflurane
(VETone isoflurane inhalation anesthetic; MWI VetOne,
Meridian, ID) was delivered by a vaporizer (Surgivet Isotec
4; Smiths Medical ASD, Inc, St Paul, MN) at a concentra-
tion of 5% for induction. The concentration was subse-
quently reduced to as low as 1% for maintenance during
handling and scanning. For 2 groups, xylazine was injected
at anesthesia (before scanning) to assess the influence of
this sedative on pulmonary capillary hemorrhage.
For all animals, the right thorax was shaved after anes-
thesia and depilated to allow good US transmission into the
body. The rats were mounted in dorsal recumbency on a
plastic board, which then was mounted vertically in a 38°C
vacuum-degassed water bath for US scanning. The water
bath maintained the body temperature of the rats and pro-
vided reliable US transmission. After scanning and a 5-
minute delay, the rat was euthanized under anesthesia by
exsanguination of the inferior vena cava. The trachea was
tied off to maintain lung volume, and the lungs were
removed for examination and photography using a stereo
microscope with a digital camera (Spot Flex; Diagnostic
Instruments, Inc, Sterling Heights, MI). 
Ultrasound Scanning
An HDI 5000 diagnostic US machine (Philips Healthcare,
Andover, MA) with a CL15-7 linear array was used for
scanning, as described previously.9 The probe was posi-
tioned in partial contact with the right thorax and used to
scan the right cranial or middle lobe. The machine was set
for real-time imaging with B-mode optimization, a 2-cm
depth, 1 focus at a 1-cm depth, and 39 frames per second.
An initial MI setting of 0.21 was used to align the probe for
a clear view of the lung. The primary variable for the thresh-
old determinations was the on-screen MI setting, with a
maximum of 0.9. The US field was characterized previ-
ously in the water bath with a calibrated hydrophone
(model 805; Sonora Medical Systems, Inc, Longmont,
CO).9 For this study, the measurements were rechecked
and found to be essentially the same. The center frequency
was approximately 7.6 MHz; the pulse repetition fre-
quency was 10 kHz; and the pulse duration was 320
nanoseconds.9 The total length of the scan was approxi-
mately 2 cm, and the –6-dB width was 1.0 mm. As before,
scanning each rat at a single MI setting was used to assess
the scan-response trends and the determination of thresh-
old MIs. The water values for peak rarefactional pressure
amplitude were derated by an attenuation coefficient of
J Ultrasound Med 2015; 34:289–297 291
Miller et al—Anesthetic Techniques Influence Pulmonary Capillary Hemorrhage in Rats
3402jum-179-332-online_Layout 1  1/20/15  10:12 AM  Page 291
1.1 dB/cm/MHz32 for the approximately 6-mm-thick rat
chest wall to obtain 0.6, 0.8, 1.2, 1.6, and 1.9 MPa, for MIs
of 0.21, 0.37, 0.52, 0.7, and 0.9, respectively.9
Experimental Plan 
The probe was aimed to obtain a clear bright image of the
lung surface, which appeared as a bright horizontal line in
the image with secondary A-lines at greater depths. For a
test, the US was quickly raised from an MI of 0.21 to the
desired MI setting for 5 minutes of scanning. For the sham-
exposed animals, the same procedure was followed, except
that the scanning at elevated MI settings was omitted. 
The images were used to obtain estimates of the width of
the bright lung surface image, the time to the first clear
appearance of a comet tail artifact, and the percentage of
the bright lung surface involved in comet tail artifacts at the
end of the scanning. The image of the scanned lung area
was used to find the length, width, and area of the hemor-
rhagic region on the lung surface with the aid of image
analysis software (Spot version 5.1; Diagnostic Instruments,
Inc).
When possible, physiologic data were collected for each
rat on the heart rate and percent peripheral capillary oxygen
saturation (SPO2) using a pulse oximeter (SurgiVet V3395
TPR; Smiths Medical ASD, Inc). This procedure produced
mixed results for both measurements due to difficulty in
placing the sensor on the paw and to the upper limit of 350
beats per minute (bpm) for the instrument. To obtain sta-
ble values, the sensor was set, and the readings were
observed for up to 5 minutes. For the pentobarbital anes-
thesia, the percent SPO2 could not be measured due to high
heart rates, which were determined from recordings from
a laboratory electrocardiographic system (ECGA ampli-
fier; Hugo Sachs Electronik, Harvard Apparatus, March,
Germany), digitizer (Powerlab 4/30; ADInstruments,
Inc, Colorado Springs, CO), and electrocardiographic
analysis software (Chart Pro 5 version 5.5.5; ADInstru-
ments, Inc).
Statistical analysis was performed using SigmaPlot
version 11.0 software for Windows (Systat Software, Inc,
San Jose, CA). The Mann-Whitney rank sum test was used
to compare means of the measured parameters, with statis-
tical significance assumed at P < .05. The z test of propor-
tions was used to assess the significance of the proportion of
5 rats that had pulmonary hemorrhage for each group
scanned at a specific MI. The proportion test was used to
locate the threshold between the lowest MI with significant
hemorrhage occurrence and the next lower MI setting.
In addition, 2-way ANOVA was used to gauge the influence
of the anesthetic methods relative to the MI variation.
Results
For anesthesia by ketamine alone (n = 15), the heart rate
and SPO2 averaged 308 ± 39 bpm and 90% ± 4%, respec-
tively, with no difference between results before and after
scanning. For the ketamine plus xylazine tests (n = 10), the
heart rate and SPO2 were 327 ± 23 bpm and 92% ± 2%
before addition of xylazine and 264 ± 18 bpm and 82% ± 4%
5 minutes after addition of xylazine. The latter results show
the possible cardiopulmonary depression induced by the
addition of xylazine with a reduced heart rate (P < .001)
and SPO2 (P < .001). The use of ketamine alone as the
anesthetic resulted in much less pulmonary capillary hem-
orrhage than was seen in the previous study.9 Scanning at
an MI of 0.37 was omitted because hemorrhage was not
seen even at the higher MI of 0.52. Results are listed in
Table 1 for the range of the times to first appearance of
comet tail artifacts, for the percentage of bright lung sur-
face images with comet tail artifacts after scanning, for the
hemorrhagic areas on the lung, and for the fractions of
lungs with positive hemorrhage results. On the basis of the
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Table 1. Results for Ketamine Anesthesia
Group, PCH Start, CTA Width, PCH Area, PCH z Test 
MI s % mm2 Fraction P
Sham NA NA 0 0/4 NA
0.52 NA NA 0 0/5 NS
0.7 210–240 2.6 ± 4.0 0.1 ± 0.2 2/5 NS
0.7–X 300 0 0.2 ± 0.2 2/5 NS
0.7+X 2–60 91 ± 10 7.2 ± 2.6 5/5 <.01
0.9 10–300 26 ± 20 1.8 ± 2.1 5/5 <.01
0.9+X 5–10 94 ± 6 14.6 ± 5.0 5/5 <.01
Means ± SDs include 0 for rats with no discernible hemorrhage, so that the observed sizes in the positive results were approximately given by
the means divided by the positive fractions. CTA indicates comet tail artifact; NA, not applicable; NS not significant; PCH, pulmonary capillary
hemorrhage; –X, test with xylazine added after scanning; +X, test with xylazine added before scanning.
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significant occurrence (5/5) at an MI of 0.9 and the lack
of significance (2/5) at an MI of 0.7, the MI threshold was
about 0.8. This finding compares to the loss of significance
between MIs of 0.52 (4/5) and 0.37 (2/5) in the previous
study, which indicated an MI threshold of about 0.44.9
The results with xylazine added before the scanning were
comparable to the previous results, but adding the xylazine
after scanning did not enhance the hemorrhage above that
seen for ketamine alone. A 2-way ANOVA for the 0.7 and
0.9 MIs without and with xylazine showed that both the
xylazine and MI had a significant influence on the results
even after allowing for the influence of the other variables;
however, the interaction effect was only marginally signif-
icant (P = .052). The direct comparison for ketamine with
xylazine given before or after scanning at an MI of 0.7
showed a dramatic increase in hemorrhage when xylazine
was present during scanning (Table 1), with a significant
difference in occurrence (P = .01). Figure 1 compares the
stereo microscopic images for the 5 repetitions of each test.
Interestingly, the 2 shallow hemorrhagic regions for
xylazine addition after scanning did not have any clear indi-
cation of comet tail artifacts in the US images, whereas the
hemorrhage that penetrated deeper into the lung (darker
regions) had comet tail artifacts extending to the bottom of
the images.
For pentobarbital anesthesia (n = 30), the heart rate
averaged 377 ± 32 bpm. The relatively high heart rate pre-
cluded SPO2 measurement. The use of pentobarbital as the
anesthetic resulted in pulmonary capillary hemorrhage that
was comparable to that seen in the previous study using
ketamine plus xylazine.9 Results are listed in Table 2 for the
same parameters as in Table 1. On the basis of the signifi-
cant occurrence (4/5) at an MI of 0.52 and insignificant
occurrence (2/5) at an MI of 0.37, the MI threshold was
about 0.44. This threshold was the same as that found for
ketamine plus xylazine in the previous study.9 No additional
tests were performed with added xylazine for pentobarbital
anesthesia because the cardiovascular and pulmonary
impact of such a combination could be detrimental.27
For isoflurane anesthesia (n = 17), the heart rate and
SPO2 averaged 343 ± 11 bpm and 91% ± 2%, respectively,
with no observed difference between the results before and
after scanning. For the 2 groups with xylazine (n = 10), the
heart rate and SPO2 were 260 ± 17 bpm and 90% ± 3%.
J Ultrasound Med 2015; 34:289–297 293
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Figure 1.  Photomicrographs of the right lung cranial lobes from 10 rats scanned at an MI of 0.7 with ketamine and without (top row) or with (bottom
row) added xylazine during scanning (Table 1). All of the lobes scanned with added xylazine have substantial pulmonary capillary hemorrhage evi-
dent within the linear extent of the scan plane. The lobes scanned without xylazine show no hemorrhage in 3 lobes and small surface evidence of
hemorrhage in 2 (black arrows). The lungs had several features that were not due to the US scanning: a fluid-filled region due to impact with a rib (white
arrow) and various wrinkles due to slight folding during removal. In addition, a few scanned or sham lungs had very small (possibly 1 alveolus) red
spots, which were not scored as pulmonary capillary hemorrhage. Scale bar indicates 5 mm.
3402jum-179-332-online_Layout 1  1/20/15  10:12 AM  Page 293
Results are listed in Table 3 for the same parameters as in
Tables 1 and 2. No tests were conducted for MIs of 0.27
and 0 (sham) because no effect was found for 5 rats scanned
at an MI of 0.37. On the basis of the significant occurrence
(5/5) at an MI of 0.9 and insignificant occurrence (2/5) at
an MI of 0.7, the MI threshold was about 0.8. This thresh-
old was the same as that found for ketamine alone (Table
1). However, when xylazine was added, pulmonary capil-
lary hemorrhage was found in 5 of 5 rats at an MI of 0.52
(P = .01) but 0 of 5 rats at an MI of 0.37. This finding indi-
cated a lowering of the threshold for isoflurane plus
xylazine to that found for pentobarbital anesthesia and ket-
amine plus xylazine anesthesia. A 2-way ANOVA for the
0.37 and 0.52 MIs without and with xylazine showed that
both the xylazine and MI had significant influence on the
results (P < .01), and that there was a significant interaction
(P = .037).
The comet tail artifact widths are presented in Figure
2 as the percentage of the lung surface seen as a bright line
in the image, shown with the means including all 5 results
(ie, 0 for the negative results). The bright line was indica-
tive of perpendicular reflection, which also often generated
repeated “A-lines” of multiple reflections at higher depths
on the image. The comet tail artifacts developed within this
bright-surface image region, which ranged from 7 to 18 mm
in width. The comet tail artifact width correlated well with
the actual width of the hemorrhagic area found in the lungs.
This plot shows the variation of pulmonary capillary hem-
orrhage induced by identical scanning but with different
anesthetic techniques, with pentobarbital giving the greatest
hemorrhage and ketamine the least. The hemorrhage with
pentobarbital was comparable to that found for ketamine
with xylazine.9 The addition of xylazine to ketamine during
scanning raised the result at an MI of 0.7 to 90% (Table 1),
which was higher than the result for pentobarbital. Likewise,
the addition of xylazine for isoflurane anesthesia at an MI
of 0.52 elevated the comet tail artifact width to 68% (Table 3),
which was about the same as for pentobarbital. Interestingly,
the low result for isoflurane at an MI of 0.7 was not signif-
icantly different from the values obtained with ketamine
but was significantly lower than the values obtained with
pentobarbital. However, the isoflurane result increased at
an MI of 0.9 so that the reverse was true: significantly greater
than the ketamine result (P < .05) but not significantly dif-
ferent from the pentobarbital result.
The areas showing pulmonary capillary hemorrhage
on the lung surface, which may be a better gauge of the mag-
nitude of the effect than the comet tail artifact, are plotted
in Figure 3. The trends were essentially the same as in
Figure 2 for comet tail artifacts. For pentobarbital anesthesia,
the increases in the areas were more pronounced with
increases in the MI than for the comet tail artifact widths.
This aspect of the 2-dimensional measurement likely
reflects the changes in the width of the ultrasonic beam,
Miller et al—Anesthetic Techniques Influence Pulmonary Capillary Hemorrhage in Rats
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Table 2. Results for Pentobarbital Anesthesia
Group, PCH Start, CTA Width, PCH Area, PCH z Test 
MI s % mm2 Fraction P
Sham NA NA 0 0/5 NA
0.27 NA NA 0 0/5 NA
0.37 7–240 32 ± 35 0.5 ± 0.9 2/5 .11
0.52 5–50 65 ± 40 4.9 ± 3.3 4/5 .01
0.7 10–90 71 ± 18 8.3 ± 4.2 5/5 <.01
0.9 1–15 100 ± 0 21.4 ± 10.5 5/5 <.01
Notations are as in Table 1.
Table 3. Results for Isoflurane Anesthesia
Group, PCH Start, CTA Width, PCH Area, PCH z Test 
MI s % mm2 Fraction P
0.37 NA NA NA 0/5 NA
0.37+X NA NA NA 0/5 NA
0.52 120–240 6.7 ± 9.3 1.3 ± 2.4 2/5 NS
0.52+X 10–60 68 ± 30 6.4 ± 4.4 5/5 <.01
0.7 2–20 23 ± 33 2.6 ± 3.9 2/5 NS
0.9 0.5–15 90 ± 14 17.5 ± 8.6 5/5 <.01
Notations are as in Table 1.
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over which the critical threshold level was exceeded.
A 2-way ANOVA for the 0.7 and 0.9 MIs and the 3 anes-
thetic methods (without xylazine) showed that the effect
of the MI on the results was significantly influenced by the
drug present (P = .047). At an MI of 0.9, ketamine was
significantly different from pentobarbital and isoflurane
anesthesia.
Discussion
In this study, the influence of different anesthetic techniques
on pulmonary capillary hemorrhage induced by diagnostic
US was investigated. The hemorrhage was greatest for
pentobarbital anesthesia, lower for isoflurane inhalational
anesthesia, and lowest for ketamine anesthesia (Figures 2
and 3), with thresholds at MIs of about 0.44, 0.8, and 0.8,
respectively. Addition of xylazine produced a substantial
increase in hemorrhage and a significant proportion of hem-
orrhage occurrence for ketamine at an MI of 0.7 (Table 1)
and for isoflurane at an MI of 0.52 (Table 3).
These results indicated that the cardiopulmonary
effects of xylazine and pentobarbital yield lower thresholds
than for ketamine or isoflurane alone by nearly a factor of
2 in MI. The time at which the comet tail artifacts were first
seen on the images provides another interesting factor for
analysis. The US interaction with the lung surface must
begin at the initial pulse. However, the changes in the
comet tail artifact start time may be viewed as changes in
the time needed to induce substantial pulmonary capillary
hemorrhage; that is, xylazine and pentobarbital may reduce
the time needed (Tables 1–3). If the experimental scan
duration were reduced (eg, from 5 minutes to 1 minute),
then the 1 of 5 and 2 of 5 results in Tables 1–3 might be
eliminated. Unfortunately, the time-to-start parameter was
somewhat subjective and variable, and the shallow
hemorrhagic areas in Figure 1 did not correspond to any
clear comet tail artifact indications. A more definitive
appraisal, for example, in terms of a temporal threshold at
each MI, would require a different method.
The variation of the sensitivity of the lungs to different
anesthetic techniques is likely due to variations in pulmonary
physiologic responses. The moderate cardiopulmonary
depression caused by xylazine or pentobarbital probably
influences the depth of respiration. The degree of lung
inflation has been shown to influence the acoustical imped-
ance of the pleural surface, such that low inflation increases
the impedance above that of a simple air-water interface.33,34
It seems possible that the respiratory depression may
therefore result in enhanced energy transmission into the
lungs and enhanced interaction with the pulmonary tissue.
The sensitivity to US-induced pulmonary capillary
hemorrhage shown for anesthesia with xylazine or pento-
barbital is likely also related to the physiologic response
of the pulmonary microvasculature. The pulmonary cap-
illary pressure is normally only about 2 to 15 mm Hg.35
Higher pressure values distend the capillaries and apply
some level of stress to the capillary border.36 Pressure values
above about 30 mm Hg are sufficient to induce edema.37
J Ultrasound Med 2015; 34:289–297 295
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Figure 2. Means ± SEs for the percentages of bright-line lung images
which were involved with comet tail artifacts (CTAs) at the end of scan-
ning (Tables 1–3). The occurrence of pulmonary capillary hemorrhage
was statistically significant for MIs of 0.5 and higher for pentobarbital but
only for an MI of 0.9 for isoflurane and ketamine-only anesthesia.
Figure 3. Means ± SEs for lung surfaces with evident pulmonary capil-
lary hemorrhage for the 3 anesthetics. As in Figure 2, the results were
statistically significantly different from shams at MIs of 0.5 and higher for
pentobarbital but only for an MI of 0.9 for isoflurane and ketamine-only
anesthesia. 
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Values higher than 40 to 50 mm Hg can cause capillary
rupture.35 Xylazine is an α2 receptor agonist and affects
the pulmonary circulation, increasing the pulmonary
capillary pressure. As noted above, relatively high doses of
xylazine, in the range of 21 to 45 mg/kg, cause pulmonary
edema in a few hours.28,29 Studies in sheep show that α2
receptor agonists similar to xylazine produce elevated pul-
monary capillary pressures in a dose-dependent manner.38,39
Pentobarbital causes cardiopulmonary depression with a
relatively high heart rate, which may also lead to pulmonary
microvascular perturbation, leading to increased pul-
monary capillary hemorrhage. Both xylazine and pento-
barbital enhanced neurogenic pulmonary edema in rats.40
The filling and distension of the capillaries are likely to reduce
the amount of exogenous stress required to rupture the cap-
illaries. Therefore, the additional stress required to cause
pulmonary capillary hemorrhage may be reduced by
xylazine or pentobarbital. The physiologic responses to
these drugs likely prestress the microvasculature and make
the capillaries vulnerable to the physical stress generated
by the exposure to pulsed US.
Most studies of pulmonary capillary hemorrhage
induced by US have used anesthetic techniques including
xylazine, which may have resulted in relatively low thresh-
olds. The observation that the milder anesthetic methods
with ketamine and isoflurane used here resulted in higher
thresholds may have implications for human pulmonary
diagnostic US. For example, ketamine alone produces a
dissociated state, which is not far from wakefulness. It is
entirely possible to extrapolate that awake healthy animals,
or patients, may be at relatively low risk of pulmonary cap-
illary hemorrhage induced by pulmonary US. Conversely,
pulmonary vulnerability may vary with different drugs and
patient conditions. For example, drugs that are α2 receptor
agonists such as clonidine (used for hypertension, attention
deficit/hyperactivity disorder, and sedation),41 may have
effects that are similar to those of xylazine. Various patient
conditions can also produce pulmonary vasodilation with
pulmonary venous hypertension. For example, left heart
impairment due to heart disease can lead to increased pul-
monary pressures and edema.42 Reduced air pressures due
to upper airway obstruction or high altitudes43 can also
lead to vasodilation and edema. These drug effects and
patient conditions may cause a relatively high risk of pul-
monary capillary hemorrhage from pulmonary US. Inter-
estingly, the use of xylazine for anesthesia in this and previous
pulmonary capillary hemorrhage research may have fortu-
itously mimicked susceptible physiologic conditions and pro-
vided data relevant to high-risk patients. Further research on
US-induced pulmonary capillary hemorrhage is needed to
clarify the problem of physiologic variability for guiding
sonographers in the safe use of pulmonary US for all
patient conditions.
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